Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Stomatitis 1Lung Neoplasms 1Head and Neck Neoplasms 1Fatigue 1Cachexia 1

Interventions

Megestrol Acetate 9Exercise 6Standard of Care 4Blood Specimen Collection 4Olanzapine 3Ibuprofen 3dermcidin 2anamorelin 2Resistance Training 2Physical Therapy Modalities 2Nutrition Assessment 2Mirtazapine 2Melatonin 2Infliximab 2Enteral Nutrition 2Dietary Supplements 2Diet Therapy 2Cyproheptadine 2testosterone enanthate 1telotristat ethyl 1remune 1ostarine 1olanzapine-fluoxetine combination 1nabiximols 1nabilone 1irinotecan sucrosofate 1fucoidan 1clazakizumab 1bermekimab 1alkaloid GB18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cachexia × clazakizumab × Clear all
NCT00866970 2020-07-09

Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia

CSL Behring

Phase 2 Completed
124 enrolled
Thoracic

Cachexia, Fatigue, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡